Clinical Trial Update: Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women

View source ↗

Summary

A completed clinical trial update assessing the use of triptans for migraine in individuals with elevated cardiovascular risk and in pregnant women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Migraine

Snippet

Sponsor: Mayo Clinic | Conditions: Migraine, Cardiovascular Diseases | Status: COMPLETED